Table 2.
ACR criteria and organ damage index in the two SLE patient groups
| Groups | Patient group I | Patient group II |
|---|---|---|
| ACR criteria, median (min-max) | 6 (4–10) | 5 (4–10) |
| Malar rash (%) | 67 | 52 |
| Discoid rash (%) | 37 | 20 |
| Photosensitivity (%) | 71 | 56 |
| Oral ulcers (%) | 27 | 26 |
| Arthritis (%) | 87 | 80 |
| Serositis (%) | 61 | 41 |
| Renal disease (%) | 42 | 34 |
| Neurological disorder (%) | 9 | 6 |
| Hematological manifestations (%) | 65 | 56 |
| Leukopenia (%) | 43 | 37 |
| Lymphopenia (%) | 33 | 26 |
| Thrombocytopenia (%) | 24 | 15 |
| Immunology (%) | 80 | 71 |
| Anti-dsDNA antibodies (%) | 74 | 61 |
| Anti-Smith antibodies (%) | 8 | 9 |
| ANA (%) | 99 | 98 |
| SLICC-DI scorea, median (min–max) | 2 (0–9) | 1 (0–8) |
aOrgan damage index